138 related articles for article (PubMed ID: 8732492)
41. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure.
Nakamura M; Yoshida H; Makita S; Arakawa N; Niinuma H; Hiramori K
Circulation; 1997 Mar; 95(5):1214-21. PubMed ID: 9054852
[TBL] [Abstract][Full Text] [Related]
42. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
[TBL] [Abstract][Full Text] [Related]
43. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans.
Hirooka Y; Egashira K; Imaizumi T; Tagawa T; Kai H; Sugimachi M; Takeshita A
J Am Coll Cardiol; 1994 Oct; 24(4):948-55. PubMed ID: 7930229
[TBL] [Abstract][Full Text] [Related]
44. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Virdis A; Ghiadoni L; Pinto S; Lombardo M; Petraglia F; Gennazzani A; Buralli S; Taddei S; Salvetti A
Circulation; 2000 May; 101(19):2258-63. PubMed ID: 10811592
[TBL] [Abstract][Full Text] [Related]
46. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
47. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA
J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095
[TBL] [Abstract][Full Text] [Related]
48. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
[TBL] [Abstract][Full Text] [Related]
49. No vasodilator response to low-dose heparin in the forearm skeletal-muscle vascular bed.
Abbink EJ; de Galan BE; van Ginneken EE; van Rosendaal AJ; Smits P
Eur J Clin Pharmacol; 2002 Apr; 58(1):7-10. PubMed ID: 11956666
[TBL] [Abstract][Full Text] [Related]
50. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes.
Taddei S; Galetta F; Virdis A; Ghiadoni L; Salvetti G; Franzoni F; Giusti C; Salvetti A
Circulation; 2000 Jun; 101(25):2896-901. PubMed ID: 10869260
[TBL] [Abstract][Full Text] [Related]
51. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Hypertension; 1997 Oct; 30(4):918-21. PubMed ID: 9336393
[TBL] [Abstract][Full Text] [Related]
52. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.
Summar ML; Gainer JV; Pretorius M; Malave H; Harris S; Hall LD; Weisberg A; Vaughan DE; Christman BW; Brown NJ
Hypertension; 2004 Feb; 43(2):186-91. PubMed ID: 14718356
[TBL] [Abstract][Full Text] [Related]
53. Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 May; 109(1):222-8. PubMed ID: 7684304
[TBL] [Abstract][Full Text] [Related]
54. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
Fryburg DA
J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
[TBL] [Abstract][Full Text] [Related]
55. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
Dietz NM; Rivera JM; Warner DO; Joyner MJ
J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
[TBL] [Abstract][Full Text] [Related]
56. Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels.
Chin-Dusting JP; Alexander CT; Arnold PJ; Hodgson WC; Lux AS; Jennings GL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):158-66. PubMed ID: 8797150
[TBL] [Abstract][Full Text] [Related]
57. Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein.
Ignarro LJ; Gold ME; Buga GM; Byrns RE; Wood KS; Chaudhuri G; Frank G
Circ Res; 1989 Feb; 64(2):315-29. PubMed ID: 2492213
[TBL] [Abstract][Full Text] [Related]
58. Role of nitric oxide in the vasodilator response to mental stress in normal subjects.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Am J Cardiol; 1997 Oct; 80(8):1070-4. PubMed ID: 9352980
[TBL] [Abstract][Full Text] [Related]
59. The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia.
Schneider MP; Hilgers KF; Huang Y; Delles C; John S; Oehmer S; Schmieder RE
Clin Sci (Lond); 2003 Jul; 105(1):97-103. PubMed ID: 12639216
[TBL] [Abstract][Full Text] [Related]
60. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Passauer J; Büssemaker E; Lässig G; Pistrosch F; Fauler J; Gross P; Fleming I
Clin Sci (Lond); 2003 Oct; 105(4):513-8. PubMed ID: 12826020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
